China Pharma Holdings, Inc.
CPHIAMEXHealthcare● Active
$0.74
+$0.03(+4.21%)
Market Cap$2351903
P/E Ratio—
52W High$2.05
52W Low$0.38
China Pharma Holdings, Inc.（CPHI）· 现金流量表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · CPHI · 截至 2026-06-10
财务报表
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | ($3.19M) | ($4.74M) | ($3.08M) | ($3.97M) | ($3.40M) |
| Depreciation & Amort. | $1.58M | $2.62M | $2.75M | $2.70M | $3.09M |
| Stock-Based Comp. | $0.00M | $0.00M | $0.00M | $0.08M | $0.02M |
| Change in Working Capital | $14.87M | $1.20M | ($0.40M) | $0.88M | $0.05M |
| Net Cash from Operations | $0.15M | ($0.47M) | ($0.70M) | ($0.41M) | ($0.25M) |
| Investing Activities | |||||
| Capital Expenditure | ($0.14M) | ($0.29M) | ($0.01M) | ($0.40M) | ($0.44M) |
| Purchases of Investments | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Sales of Investments | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Cash from Investing | ($0.14M) | ($0.29M) | ($0.01M) | ($0.40M) | ($0.44M) |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Dividends Paid | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Debt Issued / Repaid | ($0.29M) | $0.03M | $0.07M | ($1.55M) | $4.60M |
| Net Cash from Financing | ($0.29M) | $0.03M | $0.07M | ($1.77M) | $4.60M |
| Free Cash Flow | |||||
| Free Cash Flow | $0.01M | ($0.76M) | ($0.71M) | ($0.81M) | ($0.69M) |
| FCF Margin %(computed) | 0.27% | -16.74% | -10.14% | -10.01% | -7.13% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-10 · USD · M
深入了解China Pharma Holdings, Inc.
关于China Pharma Holdings, Inc.（CPHI）现金流量表
China Pharma Holdings, Inc. 2025财年经营活动现金流$0.00B，自由现金流$0.00B（FCF利润率0.27%），资本支出($0.00B)。
常见问题
CPHI · 4 问China Pharma Holdings, Inc. 2025财年自由现金流$0.00B，同比up101.5%。
CPHI free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10